Saint Louis Cancer and Breast Institute-Ballwin is a clinical research site located in Ballwin, Missouri, United States 63011.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Saint Louis Cancer and Breast Institute-Ballwin has participated in 95 clinical trials with 56 currently active.
Therapeutic areas: Prostate Carcinoma, Refractory Differentiated Thyroid Gland Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive.
Sponsors: ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Saint Louis Cancer and Breast Institute-Ballwin has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Saint Louis Cancer and Breast Institute-Ballwin has 95 clinical trials on record, with 56 currently active. Their work covers Prostate Carcinoma, Refractory Differentiated Thyroid Gland Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive.
Saint Louis Cancer and Breast Institute-Ballwin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.